Table 2.

Proportions of participants achieving clinically important improvements in physical function, fatigue and pain with corresponding risk differences

Variable	Number (%)		Risk difference (95% CI)	p Value
	Intervention group	Control group
Achieved 0.22 improvement in HAQ scores	38 (51)	4 (5)	46% (33% to 58%)	0.0001
Achieved 10 mm improvement on VAS for fatigue	46 (62)	10 (14)	48% (35% to 62%)	0.0001
Achieved 10 mm improvement on VAS for pain	47 (64)	9 (12)	51% (38% to 64%)	0.0001

HAQ, Health Assessment Questionnaire; VAS, Visual Analogue Scale.